This work is licensed under a Creative Commons Attribution 4.0 International License.
SvOrth-2
General Information
DRACP ID DRACP04955
Peptide Name SvOrth-2
Sequence NVLLSPLSVATALSALSLGAEQRTES
Sequence Length 26
UniProt ID Not available
PubChem CID Not available
Origin PEDF
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic
Disulfide/Other Bond Native peptide
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C113H195N31O40
Absent amino acids CDFHIKMWY
Common amino acids L
Mass 307408
Pl 4.26
Basic residues 1
Acidic residues 2
Hydrophobic residues 12
Net charge -1
Boman Index -1708
Hydrophobicity 48.08
Aliphatic Index 127.69
Half Life
Mammalian: 1.4 hour
Yeast: 3 min
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 9
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 21470139
Title Anti-angiogenic peptides for cancer therapeutics
Doi 10.2174/138920111796117300
Year 2011
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.